3D Printed Drugs Market Size and Forecast 2021 - 2027

report image

3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Dosage Forms (Tablets, Capsules, Multi Drug Implant, Nanoparticles, Solutions, Others); Technology (Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing, Fused Deposition Modeling, Powder Bed Printing, Stereolithography (SLA), Semi Solid Extrusion (SSE)), and Geography

Publication Month: Apr 2020 | Report Code: TIPRE00010199 | No. of Pages: 175 | Category: Medical Device | Status: Published

The 3D printed drugs marketwas valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.

3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact. The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs.The global 3D printed drugs market is driven by factors such asincreasing adoption of personalized drugs. Additionally, growing research and development activities,coupled with increasing prevalence of dysphagia,is also anticipated to drive the 3D market growth during the forecast period. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market. The developing healthcare infrastructure and increasing awareness regarding 3D printing in pharmaceuticals  generate lucrative opportunities for the growth of the market.

Lucrative Regional 3D Printed Drugs Markets

Lucrative Regional 3D Printed Drugs Markets

Get more information on this report :

Market Insights

Increasing Adoption of Personalized Drugs

Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA approved molecular entities in 2005; whereas, in 2016, they accounted for more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, and expect to increase their investment by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development over the coming five years.

3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms. Through this breakthrough method of manufacturing and its fast-melt capabilities, there is an ability to overcome several obstacles, thereby contributing to better patient outcomes in the solid dose market. For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.

Dosage Form-BasedInsights

Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. In 2019, thetabletssegment held the largest share of the market, and it is further expected to register the highest CAGR in the market during the forecast period. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years.

3D Printed Drugs Market, by Dosage Form– 2019 and 2027

3D Printed Drugs Market, by Dosage Form– 2019 and 2027

Get more information on this report :


Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). The zip dose technology segmentheld the largest share of the market; moreover, it is expected to register the highest CAGR during the forecast period.

Strategic Insights

Report Coverage - 3D Printed Drugs Market
Report CoverageDetails
Market Size Value inUS$ 28.52 Million in 2019
Market Size Value byUS$ 57.03Million by 2027
Growth rateCAGR of 9.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages175
No. of Tables74
No. of Charts & Figures53
Historical data availableYes
Segments coveredDosage Forms ; Technology , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and FDA approvalsis a commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand as the strategy allows them to expand their product portfolios.

The 3D printed drugs marketplayers also adopt the strategy ofcollaborations, which enables them enlarge their global customer base,alongside helping them maintain their brand names.

3D Printed Drugs Market – By Dosage Forms

  • Tablets
  • Capsules
  • Multi Drug Implants
  • Nanoparticles
  • Solutions
  • Others

3D Printed Drugs Market – By Technology

  • Inkjet Printing
  • Direct Write
  • Zip Dose
  • Thermal Inkjet Printing
  • Fused Deposition Modeling
  • Powder Bed Printing
  • Stereolithography (SLA)
  • Semi Solid Extrusion (SSE)

3D Printed DrugsMarket– By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America

    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • FabRx LTD
  • Cycle Pharmaceuticals
  • Tvasta
  • Merck KGGA
  • Terumo Corporation

Frequently Asked Questions

3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.
Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines
Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.

The List of Companies - 3D Printed Drugs Market

  2. FabRx LTD
  3. Cycle Pharmaceuticals
  6. Tvasta
  7. Merck KGGA
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the 3D printed drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global 3D printed drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount